About the Authors
- Romana Luger
-
Affiliation St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria
- Sneha Valookaran
-
Affiliation St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria
- Natalie Knapp
-
Affiliation St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria
- Caterina Vizzardelli
-
Affiliation St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria
- Alexander M. Dohnal
-
Affiliation St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria
- Thomas Felzmann
-
* E-mail: thomas.felzmann@activartis.com
Affiliations St. Anna Children’s Cancer Research Institute, Laboratory of Tumor Immunology, Department of Pediatrics, Medical University Vienna, Austria, Activartis Biotech GmbH, Vienna, Austria
Competing Interests
The authors have read the journal’s policy and have the following conflicts: As CEO of Activartis Biotech GmbH, a biotech company that develops a DC based cancer vaccine technology, T.F. discloses conflicting financial interests in the data presented in this paper. Activartis Biotech GmbH is a funder of this research. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials All other authors have no conflicting financial interests.
Author Contributions
Special experimental support: CV AMD. Helped to edit the manuscript: CV AMD. Conceived and designed the experiments: RL TF. Performed the experiments: RL SV NK. Analyzed the data: RL SV NK TF. Wrote the paper: RL TF.